Pharmaceutical compositions for the treatment of diseases related to neurotrophines
申请人:Guarna Antonio
公开号:US20060069092A1
公开(公告)日:2006-03-30
The present invention refers to pharmaceutical preparations including as active compounds 3-aza-bicyclo[3.2.1]octane derivatives of general formula (I) and/or their dimers of general formula (II) and (III) acting as agonists of human neurotrophines. Therefore, such compounds of formula (I), (II) and (III) are useful for treatment of diseases in which the neurotrophine functions are involved in defect, particularly of Nerve Growth Factor (NGF), such as neurodegenerative diseases of central nervous system (CNS), acquired immunodeficiency due to a reduced NGF biodisponibility, or morbous conditions in which the stimulus of neoangiogenesis process is convenient.
本发明涉及药物制剂,包括作为活性化合物的一般式(I)的3-aza-bicyclo[3.2.1]辛烷衍生物及/或其一般式(II)和(III)的二聚体,作为人类神经营养因子的激动剂。因此,公式(I),(II)和(III)的这些化合物对于治疗神经营养因子功能缺陷所涉及的疾病特别是神经系统中枢的神经退行性疾病、由于减少NGF生物可用性而导致的获得性免疫缺陷或刺激新血管生成过程方便的病态条件是有用的。